This inventor holds 1 USPTO granted patent. Top assignee: Celltrion Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Joon Woo Kim: Innovator in Antibody-Drug Conjugates
Introduction
Joon Woo Kim is a prominent inventor based in Incheon, South Korea. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody-drug conjugates. His innovative work aims to enhance the efficacy of cancer treatments.
Latest Patents
Joon Woo Kim holds a patent for an "Antibody-linker-drug conjugate, preparation method therefor, and anticancer drug composition containing same." This invention relates to a conjugate where an antibody is linked to a cytotoxic drug through an enzyme-cleavable peptide linker. This linker is capable of directly binding to a lysine residue of the antibody, which is crucial for targeted cancer therapy. He has 1 patent to his name.
Career Highlights
Joon Woo Kim is currently employed at Celltrion Inc., a leading biopharmaceutical company known for its innovative drug development. His work at Celltrion focuses on advancing therapeutic solutions that address critical health challenges.
Collaborations
He collaborates with talented colleagues, including Young Jun Park and Jin-kyo Jeong, who contribute to the research and development efforts at Celltrion Inc. Their teamwork fosters an environment of innovation and excellence in biopharmaceutical research.
Conclusion
Joon Woo Kim's contributions to the field of antibody-drug conjugates represent a significant advancement in cancer treatment. His innovative approach and collaboration with skilled professionals continue to drive progress in biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile